Lowery Frederick M. 4

What Happened
Frederick M. Lowery, Executive Vice President of Thermo Fisher Scientific (TMO), was reported as acquiring 1,638 shares via a performance-based restricted stock unit (RSU) award on February 25, 2026. The reported acquisition price is $0.00 (award grant), so the reported cash value is $0. The Compensation Committee certified achievement of the applicable performance criteria on February 25, 2026, triggering the award to vest in three equal tranches on February 28, 2026, 2027 and 2028.

Key Details

• Transaction date: February 25, 2026 (grant/acquisition code A). Report filed Feb 27, 2026.
• Shares reported: 1,638 RSUs @ $0.00 (acquisition via award).
• Vesting: Three equal tranches on 2026-02-28, 2027-02-28 and 2028-02-28 per award agreement.
• Adjustment note: A related 2023 performance RSU award’s final tranche was adjusted downward by 15% (relative TSR result), reducing the previously reported amount by 64 shares.
• Small additional holdings: The reporting person acquired 10.854 shares under the company 401(k) plan between Dec 2, 2025 and Feb 26, 2026.
• Beneficial ownership: The reporting person disclaims beneficial ownership except to the extent of any pecuniary interest (standard disclaimer).
• Shares owned after transaction: Not specified in the filing.
• Timeliness: Filing appears timely (reporting date 2/25/2026, filed 2/27/2026); no late filing indicated.

Context
This was an award/vesting event (not an open-market purchase or sale). Performance-based RSUs are compensation that convert to shares if performance targets are met; they are common executive awards and do not by themselves indicate buying or selling sentiment. The 15% reduction noted reflects the company’s relative total shareholder return result over a three-year performance period and lowered the previously reported amount by 64 shares.